Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

3.4K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Epigenetic Regulation01:46

Epigenetic Regulation

28.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Epigenetic Regulation01:46

Epigenetic Regulation

24.0K
24.0K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.0K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.0K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

30.1K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
30.1K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A presumed mouse parvovirus with overlooked high toxicity for human primitive CD34<sup>+</sup> hematopoietic precursors <i>in vitro</i> and in bone marrow-humanized mice.

Microbiology spectrum·2025
Same author

Analysis of Protein Inhibitors of Trypsin in Quinoa, Amaranth and Lupine Seeds. Selection and Deep Structure-Function Characterization of the <i>Amaranthus caudatus</i> Species.

International journal of molecular sciences·2025
Same author

2D/3D-QSAR Model Development Based on a Quinoline Pharmacophoric Core for the Inhibition of <i>Plasmodium falciparum</i>: An In Silico Approach with Experimental Validation.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

Shotgun Characterization of the Circulating IgM Antigenome of an Infectious Pathogen by Immunocapture-LC-MS/MS from Dried Serum Spots.

Journal of proteome research·2024
Same author

Co-Occurrence of G6PD Deficiency and SCT among Pregnant Women Exposed to Infectious Diseases.

Journal of clinical medicine·2023
Same author

Isolation and Characterization of NpCI, a New Metallocarboxypeptidase Inhibitor from the Marine Snail <i>Nerita peloronta</i> with Anti-<i>Plasmodium falciparum</i> Activity.

Marine drugs·2023

Related Experiment Video

Updated: Apr 27, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.1K

Epigenetic therapy reprograms hereditary disease.

José M Bautista1

  • 1COMPLUTENSE UNIVERSITY OF MADRID.

Blood
|July 5, 2014
PubMed
Summary
This summary is machine-generated.

Histone deacetylase inhibitors (HDACis) restore enzyme activity in glucose-6-phosphate dehydrogenase (G6PD)-deficient cells by enhancing gene transcription. This finding offers a promising therapeutic strategy for G6PD deficiency and other genetic disorders.

More Related Videos

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

6.5K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 27, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

6.1K
Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

6.5K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.7K

Area of Science:

  • Biochemistry
  • Genetics
  • Hematology

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder causing hemolytic anemia.
  • Severe G6PD variants lead to chronic nonspherocytic hemolytic anemia.
  • Current treatments for G6PD deficiency are limited.

Purpose of the Study:

  • To investigate the therapeutic potential of histone deacetylase inhibitors (HDACis) in G6PD-deficient cells.
  • To explore the mechanism by which HDACis affect G6PD enzyme activity.
  • To identify novel treatment strategies for genetic diseases.

Main Methods:

  • Utilized G6PD-deficient cell models.
  • Administered various HDAC inhibitors.
  • Measured G6PD enzyme activity.
  • Analyzed gene transcription levels.

Main Results:

  • HDAC inhibitors successfully reinstated G6PD enzyme activity in deficient cells.
  • This restoration was achieved by boosting gene transcription.
  • The study identified a novel mechanism for therapeutic intervention.

Conclusions:

  • HDAC inhibitors represent a promising therapeutic approach for G6PD deficiency.
  • This strategy may also be applicable to other genetic diseases.
  • Further preclinical and clinical studies are warranted.